Literature DB >> 8098843

A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).

F Saatcioglu1, P Bartunek, T Deng, M Zenke, M Karin.   

Abstract

The thyroid hormone (T3) receptor type alpha, the c-ErbA alpha proto-oncoprotein, stimulates transcription of T3-dependent promoters, interferes with AP-1 activity, and induces erythroid differentiation in a ligand-dependent manner. The v-ErbA oncoprotein does not bind hormone and has lost all of these activities. Using c-ErbA/v-ErbA chimeras, we found that a deletion of 9 amino acids, conserved among many members of the nuclear receptor superfamily, which are located at the extreme carboxy terminus of c-ErbA alpha is responsible for loss of both transactivation and transcriptional interference activities. Single, double, and triple amino acid substitutions within this region completely abolished T3-dependent transcriptional activation, interference with AP-1 activity, and decreased T3 binding by c-ErbA alpha. However, the lower T3 binding by these mutants does not fully account for the loss of transactivation and transcriptional interference, since a c-ErbA/v-ErbA chimera which was similarly reduced in T3 binding activity has retained both of these functions. Deletion of homologous residues in the retinoic acid receptor alpha (RAR alpha) resulted in a similar loss of transactivation and transcriptional interference activities. The ability of c-ErbA alpha to induce differentiation of transformed erythroblasts is also impaired by all of the mutations introduced into the conserved carboxy-terminal sequence. We conclude that this 9-amino-acid conserved region is essential for normal biological function of c-ErbA alpha and RAR alpha and possibly other T3 and RA receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098843      PMCID: PMC359836          DOI: 10.1128/mcb.13.6.3675-3685.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.

Authors:  C Schroeder; L Gibson; H Beug
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

2.  V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.

Authors:  M Sharif; M L Privalsky
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

3.  Characterization of hematopoietic cells transformed in vitro by AEV-H, a v-erbB-containing avian erythroblastosis virus.

Authors:  H Beug; P Kahn; G Doederlein; M J Hayman; T Graf
Journal:  Haematol Blood Transfus       Date:  1985

4.  The c-erb-A protein is a high-affinity receptor for thyroid hormone.

Authors:  J Sap; A Muñoz; K Damm; Y Goldberg; J Ghysdael; A Leutz; H Beug; B Vennström
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

5.  The c-erb-A gene encodes a thyroid hormone receptor.

Authors:  C Weinberger; C C Thompson; E S Ong; R Lebo; D J Gruol; R M Evans
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

6.  Erythroblast cell lines transformed by a temperature-sensitive mutant of avian erythroblastosis virus: a model system to study erythroid differentiation in vitro.

Authors:  H Beug; G Doederlein; C Freudenstein; T Graf
Journal:  J Cell Physiol Suppl       Date:  1982

Review 7.  Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation.

Authors:  T Graf; H Beug
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

8.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.

Authors:  C Schroeder; L Gibson; M Zenke; H Beug
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

View more
  36 in total

1.  Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression.

Authors:  G Achatz; B Hölzl; R Speckmayer; C Hauser; F Sandhofer; B Paulweber
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.

Authors:  V Vivat; C Zechel; J M Wurtz; W Bourguet; H Kagechika; H Umemiya; K Shudo; D Moras; H Gronemeyer; P Chambon
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states.

Authors:  I G Schulman; H Juguilon; R M Evans
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  RIP-140 interacts with multiple nuclear receptors by means of two distinct sites.

Authors:  F L'Horset; S Dauvois; D M Heery; V Cavaillès; M G Parker
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.

Authors:  J D Fondell; H Ge; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release.

Authors:  B C Lin; S H Hong; S Krig; S M Yoh; M L Privalsky
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine.

Authors:  R White; M Sjöberg; E Kalkhoven; M G Parker
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

8.  Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature.

Authors:  Frédéric Flamant; Sheue-Yann Cheng; Anthony N Hollenberg; Lars C Moeller; Jacques Samarut; Fredric E Wondisford; Paul M Yen; Samuel Refetoff
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

9.  Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer.

Authors:  Stephanie L Nott; Yanfang Huang; Aja Kalkanoglu; Kathryn Harper; Ming Chen; Scott F Paoni; Bruce M Fenton; Mesut Muyan
Journal:  Mol Med       Date:  2009-11-17       Impact factor: 6.354

10.  The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Authors:  A Bauer; W Mikulits; G Lagger; G Stengl; G Brosch; H Beug
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.